Sofiva Genomics Co., Ltd.(TW:6615)
NT$32.50+0.25 (+0.78%)
TW:6615
Sofiva Genomics Co., Ltd. Revenue
NT$32.50
At close:+0.25 (+0.78%)
Sofiva Genomics Co., Ltd. (6615) Revenue
Sofiva Genomics Co., Ltd. Revenue
Sofiva Genomics Co., Ltd. had a revenue of 97.07M in the quarter ending Jun 30, 2026, with 4.34%. This bring the company's revenue in the last twelve months to 379.21M, Decreased 0.94%. In the fiscal year ending Dec 31, 2025, Sofiva Genomics Co., Ltd. had annual revenue of 385.71M with -14.91% growth.
- Revenue (ttm)
- 379.21M
- Revenue Growth
- -6.67%
- P/S Ratio
- 1.81
- Revenue/Employee
- TWD 25,713,733
- Employees
- 15
- Market Cap
- TWD 696.39M
Revenue Chart
Sofiva Genomics Co., Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 385.71M | -67.61M | -14.91% |
| Dec 31, 2024 | 453.31M | -13.48M | -2.89% |
| Dec 31, 2023 | 466.80M | -28.98M | -5.84% |
| Dec 31, 2022 | 495.77M | -12.64M | -2.49% |
| Dec 31, 2021 | 508.42M | 19.55M | 4.00% |
| Dec 31, 2020 | 488.87M | -20.58M | -4.04% |
| Dec 31, 2019 | 509.45M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.